Liver Illness Visibility, Education, and Research Act of 2024
This bill establishes new federal funding and structural changes to address liver cancer and liver disease disparities. It allocates $45 million annually for liver cancer research, $90 million for prevention and patient tracking programs targeting high-risk communities, and $10 million for culturally appropriate awareness campaigns. The legislation redesignates the National Institute of Diabetes and Digestive and Kidney Diseases as the National Institute of Diabetes and Digestive, Kidney, and Liver Diseases, creating a new Division of Liver Diseases within the institute. It specifically aims to address higher liver cancer rates among Asian-American, Pacific Islander, and Hispanic communities, which are disproportionately affected by hepatitis B. Key provisions include creating a National Liver Diseases Data System and requiring community consultation for outreach programs.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jun 2024
Committee Review
Floor Vote
President
Introduced Jun 3, 2024
Last action Jun 7, 2024
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
3
Key actions
0
Committee
2
Jun 7, 2024
Committee
Referred to the Subcommittee on Health.
lower
Jun 3, 2024
Committee
Referred to the House Committee on Energy and Commerce.
lower
Jun 3, 2024
Introduced
Introduced in House
lower
1 primary · 7 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 8601
Scope: US
Hi! I can help you understand HR 8601. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline